This article is more than 5 years old. Information may no longer be current.

Imprimis posts 27% revenue increase in fourth quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Imprimis Pharmaceuticals reported $7.3 million in revenues in the fourth quarter of 2017, an increase of 27% from the fourth quarter of 2016, according to a press release.

The company posted a net loss of $2.8 million in the quarter compared with a net loss of $6.1 million in the fourth quarter of 2016.

For the full year, revenues increased from $20 million to $26.8 million, while the net loss decreased from $19 million in 2016 to $12 million in 2017.

Ophthalmology-related revenues totaled $5.8 million in the quarter, an increase of 64%.